IDEXX Laboratories, Inc. (NASDAQ:IDXX) Director Lawrence D. Kingsley bought 1,000 shares of the stock in a transaction on Wednesday, February 14th. The stock was acquired at an average price of $178.05 per share, with a total value of $178,050.00. Following the completion of the acquisition, the director now owns 4,558 shares of the company’s stock, valued at approximately $811,551.90. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Shares of IDEXX Laboratories, Inc. (NASDAQ IDXX) opened at $182.48 on Monday. The firm has a market capitalization of $15,898.17, a P/E ratio of 57.75, a price-to-earnings-growth ratio of 2.24 and a beta of 0.58. The company has a quick ratio of 0.80, a current ratio of 0.97 and a debt-to-equity ratio of -11.26. IDEXX Laboratories, Inc. has a 1-year low of $141.02 and a 1-year high of $198.73.
IDEXX Laboratories (NASDAQ:IDXX) last issued its earnings results on Thursday, February 1st. The company reported $0.77 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.73 by $0.04. The business had revenue of $506.00 million during the quarter, compared to the consensus estimate of $490.51 million. IDEXX Laboratories had a negative return on equity of 432.19% and a net margin of 13.36%. The firm’s revenue for the quarter was up 14.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.58 earnings per share. equities analysts anticipate that IDEXX Laboratories, Inc. will post 4.09 EPS for the current year.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. William Blair Investment Management LLC increased its holdings in shares of IDEXX Laboratories by 219.1% during the fourth quarter. William Blair Investment Management LLC now owns 728,725 shares of the company’s stock valued at $113,958,000 after acquiring an additional 500,359 shares in the last quarter. HM Payson & Co. increased its holdings in shares of IDEXX Laboratories by 7.1% during the fourth quarter. HM Payson & Co. now owns 23,569 shares of the company’s stock valued at $3,686,000 after acquiring an additional 1,563 shares in the last quarter. OLD Mutual Customised Solutions Proprietary Ltd. increased its holdings in shares of IDEXX Laboratories by 56.3% during the fourth quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 5,000 shares of the company’s stock valued at $782,000 after acquiring an additional 1,800 shares in the last quarter. MetLife Investment Advisors LLC bought a new stake in shares of IDEXX Laboratories during the fourth quarter valued at approximately $4,220,000. Finally, Gotham Asset Management LLC increased its holdings in shares of IDEXX Laboratories by 109.1% during the fourth quarter. Gotham Asset Management LLC now owns 4,620 shares of the company’s stock valued at $722,000 after acquiring an additional 2,411 shares in the last quarter. Hedge funds and other institutional investors own 86.02% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This article was originally posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://www.chaffeybreeze.com/2018/02/19/idexx-laboratories-inc-idxx-director-purchases-178050-00-in-stock.html.
About IDEXX Laboratories
IDEXX Laboratories, Inc develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.
Receive News & Ratings for IDEXX Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.